185 related articles for article (PubMed ID: 11075741)
1. Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1,030 hypercholesterolemic patients. The Cerivastatin Study Group.
Dujovne CA; Knopp R; Kwiterovich P; Hunninghake D; McBride TA; Poland M
Mayo Clin Proc; 2000 Nov; 75(11):1124-32. PubMed ID: 11075741
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of cerivastatin and pravastatin in the treatment of primary hypercholesterolemia.
Saunders E; Ferdinand K; Yellen LG; Tonkon MJ; Krug-Gourley S; Poland M
J Natl Med Assoc; 2000 Jul; 92(7):319-26. PubMed ID: 10946527
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia.
Isaacsohn J; Insull W; Stein E; Kwiterovich P; Patrick MA; Brazg R; Dujovne CA; Shan M; Shugrue-Crowley E; Ripa S; Tota R;
Clin Cardiol; 2001 Sep; 24(9 Suppl):IV1-9. PubMed ID: 11594407
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of cerivastatin 0.8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. Cerivastatin Study Group.
Insull W; Isaacsohn J; Kwiterovich P; Ra P; Brazg R; Dujovne C; Shan M; Shugrue-Crowley E; Ripa S; Tota R
J Int Med Res; 2000; 28(2):47-68. PubMed ID: 10898118
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies.
Davignon J; Hanefeld M; Nakaya N; Hunninghake DB; Insull W; Ose L
Am J Cardiol; 1998 Aug; 82(4B):32J-39J. PubMed ID: 9737644
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind comparison of cerivastatin and lovastatin for treatment of primary hypercholesterolemia.
Yu WC; Chen CH; Tsao HM; Ding YA
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Jun; 65(6):260-7. PubMed ID: 12201566
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia.
Hunninghake D; Insull W; Knopp R; Davidson M; Lohrbauer L; Jones P; Kafonek S
Am J Cardiol; 2001 Sep; 88(6):635-9. PubMed ID: 11564386
[TBL] [Abstract][Full Text] [Related]
8. Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia.
Plosker GL; Dunn CI; Figgitt DP
Drugs; 2000 Nov; 60(5):1179-206. PubMed ID: 11129127
[TBL] [Abstract][Full Text] [Related]
9. Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: a one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness.
McPherson R; Hanna K; Agro A; Braeken A;
Clin Ther; 2001 Sep; 23(9):1492-507. PubMed ID: 11589262
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of cerivastatin: phase IIa dose-ranging and dose-scheduling studies.
Hunninghake DB
Am J Cardiol; 1998 Aug; 82(4B):26J-31J. PubMed ID: 9737643
[TBL] [Abstract][Full Text] [Related]
11. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia.
Simons LA
Am J Cardiol; 2002 Oct; 90(7):737-40. PubMed ID: 12356387
[TBL] [Abstract][Full Text] [Related]
12. Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia Treatment.
Farnier M
Am J Cardiol; 1998 Aug; 82(4B):47J-51J. PubMed ID: 9737646
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
[TBL] [Abstract][Full Text] [Related]
14. Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial.
Zachoval R; Gerbes AL; Schwandt P; Parhofer KG
J Hepatol; 2001 Jul; 35(1):86-91. PubMed ID: 11495047
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia.
Saito Y; Yamada N; Teramoto T; Itakura H; Hata Y; Nakaya N; Mabuchi H; Tushima M; Sasaki J; Ogawa N; Goto Y
Atherosclerosis; 2002 Jun; 162(2):373-9. PubMed ID: 11996957
[TBL] [Abstract][Full Text] [Related]
16. [A comparative long-term trial of sodium cerivastatin, a new HMG-CoA reductase inhibitor, in patients presenting with primary hypercholesterolemia].
Sasaki J; Arakawa K; Yamamoto K; Kobori S; Ageta M; Kono S
Rev Med Interne; 1999 Aug; 20 Suppl 3():393s-398s. PubMed ID: 10480191
[TBL] [Abstract][Full Text] [Related]
17. A comparison of continuous combined hormone replacement therapy, HMG-CoA reductase inhibitor and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Ozsener S; Sendag F; Koc T; Terek MC; Oztekin K; Bilgin O
J Obstet Gynaecol Res; 2001 Dec; 27(6):353-8. PubMed ID: 11794823
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and safety of cerivastatin in the treatment of heterozygous familial hypercholesterolemia.
Mabuchi H; Koizumi J; Kajinami K
Am J Cardiol; 1998 Aug; 82(4B):52J-55J. PubMed ID: 9737647
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia.
Stein E; Isaacsohn J; Stoltz R; Mazzu A; Liu MC; Lane C; Heller AH
Am J Cardiol; 1999 May; 83(10):1433-6. PubMed ID: 10335757
[TBL] [Abstract][Full Text] [Related]
20. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
Schuster H; Barter PJ; Stender S; Cheung RC; Bonnet J; Morrell JM; Watkins C; Kallend D; Raza A;
Am Heart J; 2004 Apr; 147(4):705-13. PubMed ID: 15077101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]